BG104593A - Carboxyl substituted chroman derivatives useful as a beta 3 adrenoreceptor agonists - Google Patents
Carboxyl substituted chroman derivatives useful as a beta 3 adrenoreceptor agonistsInfo
- Publication number
- BG104593A BG104593A BG104593A BG10459300A BG104593A BG 104593 A BG104593 A BG 104593A BG 104593 A BG104593 A BG 104593A BG 10459300 A BG10459300 A BG 10459300A BG 104593 A BG104593 A BG 104593A
- Authority
- BG
- Bulgaria
- Prior art keywords
- beta
- derivatives useful
- chroman derivatives
- carboxyl substituted
- adrenoreceptor agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Peptides Or Proteins (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Pyrrole Compounds (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99462097A | 1997-12-19 | 1997-12-19 | |
PCT/US1998/026735 WO1999032476A1 (en) | 1997-12-19 | 1998-12-16 | Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BG104593A true BG104593A (en) | 2001-09-28 |
Family
ID=25540853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG104593A BG104593A (en) | 1997-12-19 | 2000-07-11 | Carboxyl substituted chroman derivatives useful as a beta 3 adrenoreceptor agonists |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1040106B1 (id) |
JP (1) | JP2001526282A (id) |
KR (1) | KR20010033188A (id) |
CN (1) | CN1284952A (id) |
AT (1) | ATE222901T1 (id) |
AU (1) | AU749097B2 (id) |
BG (1) | BG104593A (id) |
BR (1) | BR9814302A (id) |
CA (1) | CA2316971A1 (id) |
DE (1) | DE69807523T2 (id) |
DK (1) | DK1040106T3 (id) |
ES (1) | ES2183434T3 (id) |
HU (1) | HUP0004565A3 (id) |
ID (1) | ID26524A (id) |
IL (1) | IL136689A0 (id) |
NO (1) | NO20003083L (id) |
NZ (1) | NZ505200A (id) |
PL (1) | PL341229A1 (id) |
PT (1) | PT1040106E (id) |
RU (1) | RU2223269C2 (id) |
SK (1) | SK9362000A3 (id) |
TR (1) | TR200001927T2 (id) |
UA (1) | UA62993C2 (id) |
WO (1) | WO1999032476A1 (id) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR035605A1 (es) * | 2000-12-11 | 2004-06-16 | Bayer Corp | Derivados de aminometil cromano di-sustituidos, un metodo para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de medicamentos utiles como agonistas beta-3-adreno-receptores |
AR035858A1 (es) * | 2001-04-23 | 2004-07-21 | Bayer Corp | Derivados de cromano 2,6-sustituidos,composiciones farmaceuticas,uso de dichos derivados para la manufactura de medicamentos utiles como agonistas adrenorreceptores beta-3 |
WO2003033468A1 (fr) * | 2001-10-17 | 2003-04-24 | Kaneka Corporation | Procede de preparation de derives de (s)-$g(a)-halomethylpyridine-methanol |
MY147767A (en) * | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
GT200600078A (es) | 2005-02-17 | 2007-04-12 | Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquil condensados | |
US7560575B2 (en) | 2005-12-28 | 2009-07-14 | Acino Pharma Ag | Process for preparation of racemic Nebivolol |
EP1803716B1 (en) * | 2005-12-28 | 2012-07-25 | Acino Pharma AG | A process for preparation of racemic nebivolol |
ES2534336B1 (es) * | 2013-10-18 | 2016-01-28 | Artax Biopharma Inc. | Derivados de cromeno como inhibidores de la interacción TCR-Nck |
ES2534318B1 (es) * | 2013-10-18 | 2016-01-28 | Artax Biopharma Inc. | Derivados de cromeno sustituidos por alcóxido como inhibidores de la interacción TCR-Nck |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1337429C (en) * | 1983-12-05 | 1995-10-24 | Guy Rosalia Eugene Van Lommen | Derivatives of 2,2'-iminobisethanol |
GB8801306D0 (en) * | 1988-01-21 | 1988-02-17 | Ici Plc | Chemical compounds |
US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
AU675536B2 (en) * | 1993-06-14 | 1997-02-06 | Pfizer Inc. | Secondary amines as antidiabetic and antiobesity agents |
GB9405019D0 (en) * | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel compounds |
US5561142A (en) * | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
EP0801060A1 (en) * | 1996-04-09 | 1997-10-15 | Pfizer Inc. | Heterocyclic Beta-3 Adrenergenic Agonists |
-
1998
- 1998-12-16 ID IDW20001393A patent/ID26524A/id unknown
- 1998-12-16 IL IL13668998A patent/IL136689A0/xx unknown
- 1998-12-16 ES ES98963240T patent/ES2183434T3/es not_active Expired - Lifetime
- 1998-12-16 PT PT98963240T patent/PT1040106E/pt unknown
- 1998-12-16 HU HU0004565A patent/HUP0004565A3/hu unknown
- 1998-12-16 CN CN98813619A patent/CN1284952A/zh active Pending
- 1998-12-16 WO PCT/US1998/026735 patent/WO1999032476A1/en not_active Application Discontinuation
- 1998-12-16 AU AU18300/99A patent/AU749097B2/en not_active Ceased
- 1998-12-16 EP EP98963240A patent/EP1040106B1/en not_active Expired - Lifetime
- 1998-12-16 KR KR1020007006572A patent/KR20010033188A/ko not_active Application Discontinuation
- 1998-12-16 BR BR9814302-6A patent/BR9814302A/pt not_active IP Right Cessation
- 1998-12-16 PL PL98341229A patent/PL341229A1/xx not_active Application Discontinuation
- 1998-12-16 JP JP2000525413A patent/JP2001526282A/ja not_active Withdrawn
- 1998-12-16 SK SK936-2000A patent/SK9362000A3/sk unknown
- 1998-12-16 RU RU2000119110/04A patent/RU2223269C2/ru not_active IP Right Cessation
- 1998-12-16 TR TR2000/01927T patent/TR200001927T2/xx unknown
- 1998-12-16 DK DK98963240T patent/DK1040106T3/da active
- 1998-12-16 CA CA002316971A patent/CA2316971A1/en not_active Abandoned
- 1998-12-16 UA UA2000074336A patent/UA62993C2/uk unknown
- 1998-12-16 DE DE69807523T patent/DE69807523T2/de not_active Expired - Fee Related
- 1998-12-16 AT AT98963240T patent/ATE222901T1/de not_active IP Right Cessation
- 1998-12-16 NZ NZ505200A patent/NZ505200A/xx unknown
-
2000
- 2000-06-15 NO NO20003083A patent/NO20003083L/no not_active Application Discontinuation
- 2000-07-11 BG BG104593A patent/BG104593A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ATE222901T1 (de) | 2002-09-15 |
IL136689A0 (en) | 2001-06-14 |
CN1284952A (zh) | 2001-02-21 |
TR200001927T2 (tr) | 2001-06-21 |
DE69807523T2 (de) | 2003-01-09 |
EP1040106A1 (en) | 2000-10-04 |
HUP0004565A2 (hu) | 2001-08-28 |
WO1999032476A1 (en) | 1999-07-01 |
NZ505200A (en) | 2002-09-27 |
UA62993C2 (en) | 2004-01-15 |
CA2316971A1 (en) | 1999-07-01 |
PT1040106E (pt) | 2002-11-29 |
ES2183434T3 (es) | 2003-03-16 |
KR20010033188A (ko) | 2001-04-25 |
BR9814302A (pt) | 2000-10-10 |
HUP0004565A3 (en) | 2002-12-28 |
DK1040106T3 (da) | 2002-12-02 |
NO20003083D0 (no) | 2000-06-15 |
AU1830099A (en) | 1999-07-12 |
ID26524A (id) | 2001-01-11 |
EP1040106B1 (en) | 2002-08-28 |
JP2001526282A (ja) | 2001-12-18 |
AU749097B2 (en) | 2002-06-20 |
RU2223269C2 (ru) | 2004-02-10 |
NO20003083L (no) | 2000-08-15 |
DE69807523D1 (de) | 2002-10-02 |
PL341229A1 (en) | 2001-03-26 |
SK9362000A3 (en) | 2001-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY121031A (en) | Process for preparing derivatives of the taxoid family | |
BG104315A (en) | Prostaglandine agonists and their application for the treatment of osteal diseases | |
YU7797A (sh) | Kombinovana terapija za osteoporozu | |
BG103335A (en) | Application of fumaric acid derivatives | |
GB2209939B (en) | The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents | |
AU2962295A (en) | Cannabinoid receptor antagonists | |
EP0786995A4 (id) | ||
NO940789L (no) | Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse | |
EP1334719A3 (en) | Pentafluorobenzenesulfonamides and analogs | |
AP9801269A0 (en) | Prostaglandin agonists. | |
BG104593A (en) | Carboxyl substituted chroman derivatives useful as a beta 3 adrenoreceptor agonists | |
MX9804588A (es) | Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel. | |
ZA977310B (en) | Transdermal propentofylline compositions for the treatment of Alzheimer's disease. | |
IL113178A0 (en) | 8 alpha-3-hydroxyestra-1,3,5(11) tetraen-17-one (delta9(11)-dehydro-8 isoestrone its preparation andpharmaceutical composition containing it and its use | |
WO2002048134A3 (en) | Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists | |
AR006616A1 (es) | Derivados carboxilicos utiles como inhibidores de los receptores de las endotelinas y composiciones farmaceuticas que los contienen | |
ATE402933T1 (de) | Neue sulfonamid-substituierte chroman-derivate verwendbar als beta 3 adrenorezeptor agonisten | |
AU634003B2 (en) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
BG103649A (en) | Method for the preparation of eprosartan | |
BG104427A (en) | Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis | |
BG103650A (en) | Method for the preparation of eprosartan | |
AU2567097A (en) | Novel vitamin d analogues | |
AU8552098A (en) | Pyrazoloquinolinone derivatives as gaba alpha 5 receptor inverse agonists | |
BG104373A (en) | Polymorphous forms of dofetilide | |
SI1040106T1 (en) | Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |